Severe iatrogenic bismuth poisoning with bismuth iodoform paraffin paste treated with DMPS chelation

Clinical Toxicology

Volumn 46, Issue 9, 2008, Pages 855-857

  Ovaska, Hanna ^a   Wood, David M ^a   House, Ivan ^a   Dargan, Paul I ^a   Jones, Alison L ^b   Murray, Shona ^c  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Bismuth; Chelation; DMPS; Encephalopathy; Toxicity

Indexed keywords

BISMUTH; UNITHIOL;

AGED; ARTICLE; BRAIN DISEASE; CASE REPORT; CHELATION; HEAVY METAL POISONING; HUMAN; MALE; METAL IMPLANTATION; NEUROTOXICITY;

AGED; ANTIDOTES; BISMUTH; CHELATING AGENTS; DRUG COMBINATIONS; HUMANS; HYDROCARBONS, IODINATED; MALE; PELVIC NEOPLASMS; POSTOPERATIVE COMPLICATIONS; UNITHIOL; WOUND HEALING;

EID: 55949103534     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650801953182     Document Type: Article

References (16)

1. Chevretton EB, McRae RDR, Booth JB. Mastoidectomy packs: xeroform or BIPP. J Laryngol Otol 1991; 105:916-917.
2. Sharma RR, Cast IP, Redfern RM, O'Brien C. Extradural application of bismuth iodoform paraffin paste causing relapsing bismuth encephalopathy: a case report with CT and MRI studies. J Neurol Neurosurg Psychiatry 1994; 57:990-993.
3. Bridgeman AM, Smith AC. Iatrogenic bismuth poisoning - a case report. Aust Dent J 1994; 39:279-281.
4. Baselt RC. Bismuth. In: Baselt RC, ed. Disposition of Toxic Drugs and Chemicals in Man. 7th ed. Foster City, California, USA: Biomedical Publications, 2004:119-121.
5. Nigam A, Allwood MC. BIPP - How does it work. Clin Otolaryngol Allied Sci 1990; 15:173-175.
6. Slikkerveer A, de Wolff FA. Pharmacokinetics and toxicity of bismuth compounds. Med Toxicol Adverse Drug Exp 1989; 4:303-323.
7. Stoltenberg M. Retrograde axonal transport of bismuth: an autometallographic study. Acta Neuropathol (Berl) 2001; 101:123-128.
8. Lavelle K, Doedens DJ, Kleit SA, Forney RB. Iodine absorption in burn patients treated topically with povidone-iodine. Clin Pharmacol Ther 1975; 17:355-362.
9. Slikkerveer A. Bismuth poisoning and chelation. J Clin Tox 1993; 31:365-366.
10. Dimercaprol Injection BP (Sovereign Medical) Summary of Product Characteristics. http://www.emc.medicines.org.uk/eMC/assets/c/html/ displayDocPrinterFriendly.asp?DocumentID=10794. Accessed 7 January 2008.
11. Slikkerveer A, Jong HB, Helmich RB, de Wolff FA. Development of a therapeutic procedure for bismuth intoxication with chelation agents. J Lab Clin Med 1992; 119:529-537.
12. Slikkerveer A, Noach LA, Tytgat GNJ, Van der Voet GB, de Wolff FA. Comparison for enhanced elimination of bismuth in humans after treatment with meso-2,3-dimercaptosuccinic acid and D,L-2,3-dimercaptopropane-1-sulfonic acid. Analyst 1998; 123:91-92.
13. Playford RJ, Matthews CH, Campbell MJ, Delves HT, Hla KK, Hodgson HJ, Calam J. Bismuth induced encephalopathy in a patient with chronic renal failure. Gut 1990; 31:359-360.
14. Stevens PE, Moore DF, House IM, Volans GN, Rainford DJ. Significant elimination of Bismuth by Haemodialysis with a new heavy-metal chelating agent. Nephrol Dial Transplant 1995; 10:696-698.
15. Hruby K, Donner A. 2,3-Dimercapto-1-propanesulphonate in heavy metal poisoning. Med Toxicol Adverse Drug Exp 1987; 2:317-323.
16. Poisoning with Toxic Metals and Organometallic Compounds. In Flanagan RJ, ed. Antidotes. 1st ed. London: Taylor & Francis; 2001:60-62.